Phase
Condition
Interstitial Cystitis
Overactive Bladder
Enuresis
Treatment
N/AClinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Met clinical criteria under outside care or during the Principal Investigator'sroutine standard of care for BoNT injection therapy
No contraindication to BoNT therapy as outlined by drug manufacturer guidelines
Participants have elected to have the BoNT injection therapy prior to being offeredenrollment into the study for either overactive bladder (OAB), neurogenic detrusoroveractivity (NDO), or refractory interstitial cystitis (IC)
Exclusion
Exclusion Criteria:
Currently pregnant
Currently nursing a baby
Anticipated geographic relocation within the first 3 months following treatment
Allergy to morphine, belladonna, or opiates
Patients will be excluded if participating in another research study
Individuals unable to provide informed consent or to complete two-week follow-upbladder testing (post-void residual) or data collection will also be excluded
Study Design
Connect with a study center
University of Kansas School of Medicine - Wichita
Wichita, Kansas 67214
United StatesSite Not Available
Wichita Women's Pelvic Surgery Center at Associates in Women's Health
Wichita, Kansas 67208
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.